BioXcel Therapeutics, Inc. Common Stock (BTAI)

Typically moves ±11.12% on earnings
EARNINGS ANALYTICS
event_upcoming Est. Next Earnings: 2026-11-13 ESTIMATED
search

BioXcel Therapeutics, Inc. Common Stock (BTAI) has reported earnings 20 times since Aug 10, 2021. The stock moves an average of ±11.12% the day after reporting, closing higher 35.0% of the time. Its largest post-earnings gain was +29.41% (Nov 10, 2022) and its largest decline was -41.4% (Aug 14, 2023). The next earnings report is predicted for 2026-11-13 (estimated).

Earnings reactions

How BTAI moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

20

Avg Abs. Movement

±11.12%

Positive %

35.0%

Negative %

65.0%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
May 15, 2026 ☀ PRE -5.35% open_in_new
Mar 27, 2026 ☀ PRE -7.35% open_in_new
Nov 12, 2025 ☀ PRE -16.01% open_in_new
Aug 12, 2025 ☀ PRE +5.48% open_in_new
event

Earnings Count

20

Total earnings in dataset

trending_up

Avg Abs. Movement

±11.12%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 12 →
12
Funds holding
$729164
Total value held
Buying
7 added · 2 reduced
Blackrock, Inc.
$253001 +112.90%
Ubs Group Ag
$222871 NEW BUY
State Street Corp
$129886 Held
Northern Trust Corp
$79408 +55.09%
Stonex Group Inc.
$29164 NEW BUY

Frequently asked about BTAI earnings

When does BioXcel Therapeutics, Inc. Common Stock report earnings next? expand_more

BioXcel Therapeutics, Inc. Common Stock (BTAI)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does BTAI stock move after earnings? expand_more

Over 20 reports, BTAI has moved an average of ±11.12% the session after earnings, closing higher 35.0% of the time.

What was BTAI's biggest post-earnings move? expand_more

BTAI's largest post-earnings gain on record was +29.41% on Nov 10, 2022, and its largest decline was -41.4% on Aug 14, 2023.

Where can I find BioXcel Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of BioXcel Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.